Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study

To compare the efficacy of antipsychotics (APs) for delirium treatment in patients with cancer, 27 patients treated with 1 of the 4 APs, haloperidol (HPD), risperidone (RIS), olanzapine (OLZ), and quetiapine (QTP), were divided into 2 groups: long half-life (T1/2; HPD, RIS, and OLZ) versus short T1/...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hospice & palliative medicine 2016-06, Vol.33 (5), p.456-462
Hauptverfasser:	Tanimukai, Hitoshi, Tsujimoto, Hiroshi, Matsuda, Yoshinobu, Tokoro, Akihiro, Kanemura, Seitetsu, Watanabe, Motoo, Tsujio, Ichiro, Maeda, Isseki, Takei, Kiyozumi, Nakajima, Shinichiro, Taira, Toshihiro, Tokuyama, Madoka, Kai, Toshihiro, Okamoto, Yoshiaki, Goya, Sho, Kashiwagi, Yujiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antipsychotic Agents - administration & dosage Antipsychotic Agents - pharmacokinetics Antipsychotic Agents - therapeutic use Benzodiazepines - pharmacokinetics Benzodiazepines - therapeutic use Cross-Sectional Studies Delirium - drug therapy Delirium - etiology Female Half-Life Haloperidol - pharmacokinetics Haloperidol - therapeutic use Humans Male Middle Aged Neoplasms - complications Nursing Quetiapine Fumarate - pharmacokinetics Quetiapine Fumarate - therapeutic use Risperidone - pharmacokinetics Risperidone - therapeutic use Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!